ONC
BeOne Medicines Ltd.
BeOne Medicines Ltd. (ONC) has 32 SEC Form 4 filings (121 transaction rows) in the rolling window, disclosed by 10 distinct insiders. Most recent filing: Jul 15, 2026.
The most active filer is Chief Executive Officer OYLER JOHN with 8 filings. Insiders have net sold $68.0M over the trailing 6 months.
- Industry:Biotechnology
- CEO:John V. Oyler
- Employees:12,000
- HQ:Basel, PA, US
- IPO:2016-02-03
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$108.0M
reported sales (SEC code S)
Unique Insiders
10
in the rolling window
Market Cap
$449.9B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Chief Executive Officer | Sale | 145,861 | $44.6M | Jul 15 | SEC ↗ | |
| Chief Executive Officer | Sale | 11,698 | $3.5M | Jul 15 | SEC ↗ | |
| Chief Executive Officer | Sale | 48,520 | $14.8M | Jul 15 | SEC ↗ | |
| SVP, General Counsel | Sale | 664 | $201K | Jul 10 | SEC ↗ | |
| Chief Executive Officer | Sale | 3,410 | $934K | Jun 25 | SEC ↗ | |
| President and COO | Sale | 1,292 | $357K | Jun 25 | SEC ↗ | |
| President, Global Head of R&D | Sale | 1,068 | $296K | Jun 25 | SEC ↗ | |
| Chief Executive Officer | Sale | 3,693 | $981K | Jun 18 | SEC ↗ | |
| President and COO | Sale | 1,357 | $362K | Jun 18 | SEC ↗ | |
| President, Global Head of R&D | Sale | 1,169 | $310K | Jun 18 | SEC ↗ | |
| SVP, General Counsel | Sale | 590 | $157K | Jun 18 | SEC ↗ | |
Ball Titus B.First filing | Principal Accounting Officer | Sale | 169 | $43K | Jun 15 | SEC ↗ |
Wang LaiFirst filing | President, Global Head of R&D | Sale | 756 | $197K | Jun 15 | SEC ↗ |
Rosenberg AaronFirst filing | Chief Financial Officer | Sale | 631 | $163K | Jun 15 | SEC ↗ |
Wu XiaobinFirst in 7 months | President and COO | Sale | 626 | $164K | Jun 15 | SEC ↗ |
Lee Chan HenryFirst in 6 months | SVP, General Counsel | Sale | 428 | $110K | Jun 15 | SEC ↗ |
OYLER JOHNFirst in 6 months | Chief Executive Officer | Sale | 1,949 | $501K | Jun 15 | SEC ↗ |
Riva AlessandroFirst filing | Director | Sale | 212 | $66K | May 27 | SEC ↗ |
Dugan MargaretFirst filing | Director | Sale | 212 | $66K | May 27 | SEC ↗ |
Sanders Corazon (Corsee) D.First filing | Director | Sale | 212 | $66K | May 27 | SEC ↗ |
BAKER BROS. ADVISORS LPFirst filing | Director | Sale | 5,499 | $131K | May 27 | SEC ↗ |
OYLER JOHNFirst filing | Chief Executive Officer | Sale | 75,631 | $23.3M | Dec 17 | SEC ↗ |
OYLER JOHNFirst filing | Chief Executive Officer | Sale | 24,369 | $7.4M | Dec 17 | SEC ↗ |
Lee Chan HenryFirst in 3 months | SVP, General Counsel | Sale | 332 | $106K | Dec 12 | SEC ↗ |
Lee Chan HenryFirst in 3 months | SVP, General Counsel | Sale | 332 | $108K | Dec 12 | SEC ↗ |
Wu XiaobinFirst filing | President and COO | Sale | 10,000 | $3.6M | Nov 14 | SEC ↗ |
Wu XiaobinFirst filing | President and COO | Sale | 6,009 | $2.3M | Nov 14 | SEC ↗ |
Lee Chan HenryFirst filing | SVP, General Counsel | Sale | 10,006 | $3.3M | Sep 12 | SEC ↗ |
Related companies
BeOne Medicines Ltd. is in the Healthcare sector.